Bourgeois, B., Spreitzer, E., Platero-Rochart, D., Paar, M., Zhou, Q., Usluer, S., Keizer, P. L. J. D., Burgering, B. M. T., Sánchez-Murcia, P. A., Madl, T. (2025). The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4-DRI. Nature Communications. https://doi.org/10.1038/s41467-025-60844-9